Overview

Gender

male

Yoav Doppelt has served as Chairman of our board of directors since October 2011 and a director of Enzymotec since 2001. Doppelt has served as the Chief Executive Officer of XT Investments Ltd.

since its inception in 2007 and has held various finance and managerial positions within the XT Group (formerly known as the Ofer Group), including Chief Executive Officer of XT Hi-Tech Investments (1992) Ltd., which is an indirect wholly-owned subsidiary of XT Investments Ltd.

Doppelt currently serves as a member of the board of directors of a number of companies, including Israel Corporation Ltd., TowerJazz Ltd., Lumenis Ltd., MGVS Ltd., Yozma III Management and Investments Ltd., RayV Inc. and Angioslide Ltd. Doppelt has been actively involved in numerous investments within the Israeli private equity, healthcare and technology arenas.

He has extensive business experience which varies from growth companies to large conglomerates through his board membership in Israel Corporation Ltd. He holds a bachelor’s degree in economics and management from the Faculty of Industrial Management at the Technion — Israel Institute of Technology, Haifa, Israel, and an MBA degree from Haifa University, Israel.